Page 227 - Read Online
P. 227

Erkan et al. Mini-invasive Surg 2018;2:30                      Mini-invasive Surgery
               DOI: 10.20517/2574-1225.2018.51




               Review                                                                        Open Access


               Current state of transanal minimally invasive
               surgery in the management of rectal cancer

               Arman Erkan, Justin J. Kelly, John R. T. Monson

               Center for Colon & Rectal Surgery, AdventHealth, Orlando, FL 32804, USA.

               Correspondence to: Dr. John R.T. Monson, Center for Colon & Rectal Surgery, AdventHealth, Orlando, FL 32804, USA.
               E-mail: john.monson.md@flhosp.org

               How to cite this article: Erkan A, Kelly JJ, Monson JRT. Current state of transanal minimally invasive surgery in the management
               of rectal cancer. Mini-invasive Surg 2018;2:30. http://dx.doi.org/10.20517/2574-1225.2018.51
               Received: 11 Jul 2018    First Decision: 23 Aug 2018    Revised: 3 Sep 2018    Accepted: 4 Sep 2018    Published: 26 Sep 2018

               Science Editor: Gordon N. Buchanan    Copy Editor: Cui Yu    Production Editor: Huan-Liang Wu



               Abstract
               Rectal cancer surgery has undergone a rapid change over the last few decades. We have come a long way from
               abdominoperineal resection to minimally invasive sphincter preserving techniques. Colorectal cancer screening
               programs made it possible to diagnose patients at earlier stages and this has led to question the necessity of radical
               surgery and the possibility of organ preservation. The platform most recently added to the surgical armamentarium is
               transanal minimally invasive surgery (TAMIS). It utilizes conventional laparoscopic tools to perform endoluminal surgery
               in rectum. Along with the conceptual changes in rectal cancer management, TAMIS is more frequently used for local
               excision of malignant rectal tumors. This review highlights the recent advances and current state of the role of TAMIS in
               the management of rectal cancer at various stages.

               Keywords: Rectal cancer, transanal minimally invasive surgery, local excision




               INTRODUCTION
               The ultimate aim of rectal cancer treatment is to provide safe oncological cure while maintaining enteral
               continuity and preserving sphincter function. In many cases, it is challenging to achieve excellent results
                                   [1]
               in all three components .

               The multimodal treatment of rectal cancer is following a similar path to breast cancer: less invasive surgi-
               cal techniques are being utilized to preserve anatomical and functional integrity without compromising
               oncological outcomes. It has undergone a seismic change from abdominoperineal resection to low anterior
               resection, local excision and finally watch-and-wait approach, following neoadjuvant treatment in select

                           © The Author(s) 2018. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                    www.misjournal.net
   222   223   224   225   226   227   228   229   230   231   232